NEW YORK (GenomeWeb) – Genedrive announced today that it has signed a distribution agreement with Sysmex Asia Pacific for its Genedrive HCV ID kit and Genedrive PCR platform in the Asia Pacific region.
As part of the agreement, Genedrive retains responsibility for product development, quality management, and manufacturing. Sysmex will be responsible for sales, marketing, customer support, and distribution activities across the region. In addition, Genedrive currently retains the rights over the Indian market.
The companies plan to secure required regulatory approvals in individual territories across Asia.
The Genedrive HCV assay runs on the Genedrive PCR platform, and provides results directly from plasma samples without a separate viral RNA extraction step.
"This agreement provides access to another important and very relevant global region for Genedrive encompassing countries with a high HCV burden," Genedrive CEO David Budd said in a statement.
In October, Genedrive announced a distribution agreement with Sysmex Europe covering Europe, the Middle East, and Africa for the Genedrive HCV ID kit and Genedrive platform.
Also, earlier this month Genedrive said that it had terminated a distribution deal for its tuberculosis and antibiotic-resistance test with Xcelris Labs in India.